Evidence map›Paper›PMID 31064987›Full record

ArticleNature communications2019

Regeneration of severely damaged lungs using an interventional cross-circulation platform.

Brandon A Guenthart, John D O'Neill, Jinho Kim, Dawn Queen, Scott Chicotka, Kenmond Fung, Michael Simpson, Rachel Donocoff, Michael Salna, Charles C Marboe and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 57 citations in OpenAlex.

  1. Optimized cellular perfusate increases lung viability ex vivo and extends the duration of ex vivo lung perfusion.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Article
  2. Lung rehabilitation using xenogeneic cross-circulation does not lead to hyperacute rejection in a human lung transplantation model.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  3. Article
  4. Article
  5. Recovery of extracorporeal lungs using cross-circulation with injured recipient swine.The Journal of thoracic and cardiovascular surgery · 2024
    Article
  6. Article
  7. Machine Perfusion and Bioengineering Strategies in Transplantation-Beyond the Emerging Concepts.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  8. Article
  9. Article
  10. Technique for xenogeneic cross-circulation to support human donor lungs ex vivo.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Article
  11. An Introduction to Engineering and Modeling the Lung.Advances in experimental medicine and biology · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Imaging-Guided Bioreactor for Generating Bioengineered Airway Tissue.Journal of visualized experiments : JoVE · 2022
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Brandon A GuenthartDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
John D O'NeillDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Jinho KimDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Dawn QueenDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Scott ChicotkaDepartment of Surgery, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Kenmond FungDepartment of Clinical Perfusion, Columbia University Medical Center, Columbia University, New York, NY, 1003, USA.
Michael SimpsonDepartment of Surgery, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Rachel DonocoffInstitute of Comparative Medicine, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Michael SalnaDepartment of Surgery, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Charles C MarboeDepartment of Pathology and Cell Biology, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Katherine CunninghamDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Susan P HalliganDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Holly M WobmaDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Ahmed E HozainDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Alexander RomanovInstitute of Comparative Medicine, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA.
Gordana Vunjak-NovakovicDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA. gv2131@cvolumbia.edu.ORCID http://orcid.org/0000-0002-9382-1574
Matthew BacchettaDepartment of Biomedical Engineering, Columbia University Medical Center, Columbia University, New York, NY, 10032, USA. matthew.bacchetta@vumc.org.
Columbia University Irving Medical Center · USStevens Institute of Technology · USVanderbilt University · US

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
POSTDOCTORAL TRAINING IN CARDIOVASCULAR DISEASET32HL007854 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Marwah Abdalla, Michael Argenziano · 1996 to 2026
$14.7M
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosisU01HL134760 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E, VUNJAK-NOVAKOVIC, GORDANA · 2016 to 2022
$8.5M
NHLBI NIH HHS T32 HL007854NHLBI NIH HHS U01 HL134760NIBIB NIH HHS P41 EB002520
6 · The paper itself

Abstract

The number of available donor organs limits lung transplantation, the only lifesaving therapy for the increasing population of patients with end-stage lung disease. A prevalent etiology of injury that renders lungs unacceptable for transplantation is gastric aspiration, a deleterious insult to the pulmonary epithelium. Currently, severely damaged donor lungs cannot be salvaged with existing devices or methods. Here we report the regeneration of severely damaged lungs repaired to meet transplantation criteria by utilizing an interventional cross-circulation platform in a clinically relevant swine model of gastric aspiration injury. Enabled by cross-circulation with a living swine, prolonged extracorporeal support of damaged lungs results in significant improvements in lung function, cellular regeneration, and the development of diagnostic tools for non-invasive organ evaluation and repair. We therefore propose that the use of an interventional cross-circulation platform could enable recovery of otherwise unsalvageable lungs and thus expand the donor organ pool.

Indexed as

Lung TransplantationAnimalsCross CirculationDisease Models, AnimalHumansLungOrgan PreservationPerfusionPulmonary Disease, Chronic ObstructiveRegenerationRespiratory Aspiration of Gastric ContentsSwineSwine, MiniatureTissue and Organ HarvestingTissue Donors

Identifiers

PMID31064987
PMCPMC6504972
OpenAlexW2944702757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.